ÎÞÓǶÌÊÓƵ

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2020 $ 41,747,957 $ 21,771 $ 89,505,216 $ (70,000) $ (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 Ìý 21,770,520 Ìý Ìý Ìý
Ending balance at Jul. 31, 2020 43,678,736 $ 22,378 92,378,584 (70,000) (48,652,226)
Ending balance (in shares) at Jul. 31, 2020 Ìý 22,377,744 Ìý Ìý Ìý
Beginning balance at Apr. 30, 2020 41,747,957 $ 21,771 89,505,216 (70,000) (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 Ìý 21,770,520 Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 2,318,658 Ìý 2,318,658 Ìý Ìý
Common stock issued for stock options exercised for cash 2,215,315 $ 918 2,214,397 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 917,587 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 22 (22) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 22,339 Ìý Ìý Ìý
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601 Ìý Ìý
Common stock issued for conversion of Convertible Notes (in shares) Ìý 1,398,602 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 132 (132) Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 132,109 Ìý Ìý Ìý
Common stock issued for warrants exercised for cash 1,081,791 $ 191 1,081,600 Ìý Ìý
Common stock issued for warrants exercised for cash (in shares) Ìý 192,049 Ìý Ìý Ìý
Modification charge for warrants exercised 25,966 Ìý 25,966 Ìý Ìý
Amortization of warrant based cost 18,250 Ìý 18,250 Ìý Ìý
Cancellation of Treasury Stock 0 $ (17) (69,983) 70,000 Ìý
Cancellation of Treasury Stock (in shares) Ìý (16,667) Ìý Ìý Ìý
Net loss (5,313,721) Ìý Ìý Ìý (5,313,721)
Ending balance at Oct. 31, 2020 52,094,216 $ 24,416 105,092,551 0 (53,022,751)
Ending balance (in shares) at Oct. 31, 2020 Ìý 24,416,539 Ìý Ìý Ìý
Beginning balance at Jul. 31, 2020 43,678,736 $ 22,378 92,378,584 (70,000) (48,652,226)
Beginning balance (in shares) at Jul. 31, 2020 Ìý 22,377,744 Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 1,831,548 Ìý 1,831,548 Ìý Ìý
Common stock issued for stock options exercised for cash 945,332 $ 502 944,830 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 502,412 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 22 (22) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 22,339 Ìý Ìý Ìý
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601 Ìý Ìý
Common stock issued for conversion of Convertible Notes (in shares) Ìý 1,398,602 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 132 (132) Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 132,109 Ìý Ìý Ìý
Amortization of warrant based cost 9,125 Ìý 9,125 Ìý Ìý
Cancellation of Treasury Stock 0 $ (17) (69,983) 70,000 Ìý
Cancellation of Treasury Stock (in shares) Ìý (16,667) Ìý Ìý Ìý
Net loss (4,370,525) Ìý Ìý Ìý (4,370,525)
Ending balance at Oct. 31, 2020 52,094,216 $ 24,416 105,092,551 0 (53,022,751)
Ending balance (in shares) at Oct. 31, 2020 Ìý 24,416,539 Ìý Ìý Ìý
Beginning balance at Apr. 30, 2021 49,090,474 $ 25,067 109,040,824 (1,817,414) (58,158,003)
Beginning balance (in shares) at Apr. 30, 2021 Ìý 25,066,297 Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 1,264,870 Ìý 1,264,870 Ìý Ìý
Common stock issued for stock options exercised for cash 56,034 $ 17 56,017 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 16,752 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 30 (30) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 30,156 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 35 (35) Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 34,989 Ìý Ìý Ìý
Amortization of warrant based cost 27,583 Ìý 27,583 Ìý Ìý
Warrants issued for deferred financing costs related to Credit Facility 137,500 Ìý 137,500 Ìý Ìý
Net loss (3,723,146) Ìý Ìý Ìý (3,723,146)
Ending balance at Oct. 31, 2021 46,853,315 $ 25,149 110,526,729 (1,817,414) (61,881,149)
Ending balance (in shares) at Oct. 31, 2021 Ìý 25,148,194 Ìý Ìý Ìý
Beginning balance at Jul. 31, 2021 48,796,304 $ 25,088 109,617,521 (1,817,414) (59,028,891)
Beginning balance (in shares) at Jul. 31, 2021 Ìý 25,087,051 Ìý Ìý Ìý
Increase (Decrease) in Stockholders' Equity [Roll Forward] Ìý Ìý Ìý Ìý Ìý
Stock-based compensation 722,158 Ìý 722,158 Ìý Ìý
Common stock issued for stock options exercised for cash 33,486 $ 12 33,474 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) Ìý 11,655 Ìý Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 30 (30) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 30,156 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 19 (19) Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 19,332 Ìý Ìý Ìý
Amortization of warrant based cost 16,125 Ìý 16,125 Ìý Ìý
Warrants issued for deferred financing costs related to Credit Facility 137,500 Ìý 137,500 Ìý Ìý
Net loss (2,852,258) Ìý Ìý Ìý (2,852,258)
Ending balance at Oct. 31, 2021 $ 46,853,315 $ 25,149 $ 110,526,729 $ (1,817,414) $ (61,881,149)
Ending balance (in shares) at Oct. 31, 2021 Ìý 25,148,194 Ìý Ìý Ìý